MLNT - Melinta Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1122
Avg. Estimate-2.77-1.89-8.96-4.32
Low Estimate-2.77-1.89-11.07-4.55
High Estimate-2.77-1.89-6.85-4.1
Year Ago EPS-3.94-2.34-17.12-8.96
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1122
Avg. Estimate22.3M17.4M69.7M126.4M
Low Estimate22.3M17.4M69M88M
High Estimate22.3M17.4M70.4M164.8M
Year Ago Sales35.49M14.08M96.43M69.7M
Sales Growth (year/est)-37.20%23.50%-27.70%81.30%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-4.32-2.88-2.59-2.55
EPS Actual-3.94-2.34-3.07-15.67
Difference0.380.54-0.48-13.12
Surprise %8.80%18.80%-18.50%-514.50%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-2.77-1.89-8.96-4.32
7 Days Ago-2.77-1.89-8.96-4.32
30 Days Ago-2.53-1.93-13.18-5.91
60 Days Ago-2.62-1.77-9.71-5.62
90 Days Ago-2.73-1.89-9.78-5.42
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMLNTIndustrySectorS&P 500
Current Qtr.29.70%N/AN/A0.01
Next Qtr.19.20%N/AN/A0.06
Current Year47.70%N/AN/A-0.02
Next Year51.80%N/AN/A0.14
Next 5 Years (per annum)96.80%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A